Product Code: PM2570
The global hormonal contraceptive market size is expected to reach USD 23.81 billion by 2030, according to a new study by Polaris Market Research. The report "Hormonal Contraceptive Market Share, Size, Trends, Industry Analysis Report, By Product; By Hormones (Combined Hormonal Contraceptive, Progestin-only Contraceptive); By Age; By End-Use; By Region; Segment Forecast, 2022 - 2030" gives a detailed insight into current market dynamics and provides an analysis of future market growth.
A significant increase in government activity to control population growth, awareness about family planning, and the need to prevent unplanned pregnancies showcases growth in the industry. Furthermore, the investments and availability of a diverse range of innovative preventive products and key significant players working on preventives are expected to drive industry growth.
In addition, other factors that are expected to propel substantial growth opportunities include rising awareness about unplanned pregnancies among teenagers. Many Asia Pacific regions such as India, China, and Japan are likely to positively impact the growth of the industry owing to updated technologies and targeted populations in these regions.
COVID-19 had a negative impact on the industry due to the lockdown and economic slowdown. It has declined supply chain and manufacturing of the preventive products, which was stabilized post-pandemic.
Hormonal contraceptives Market Report Highlights
The demand for the combined contraceptive segment is expected to drive the market growth as demand for fewer side effects, effective and lower acne prone and other symptoms are growing over time.
Based on product, oral pills are accounted to contribute towards higher revenue for the market as they are conveniently available and have high accuracy.
Household segment by end-use is expected to spearhead revenue growth in the forecast period due to ease of consumption at home to avoid unplanned pregnancy.
Asia Pacific is anticipated to grow at a CAGR of xx over the forecast period due to high unmet needs and more women moving towards their reproductive age.
Major players operating in the industry include Ansell ltd, Abbvie Inc, Afaxys inc, Agile Therapeutics, Bayer AG, Pfizer, inc, Church & Dwight,Co,Inc, Janssen Pharmaceuticals Inc., Lupin Pharmaceuticals Inc., Mylan N.V., Mayer Laboratories, Merck & co,Inc, Organon Group of companies, Pregna International Ltd, The Female Health Company
Polaris Market Research has segmented the Hormonal Contraceptive market report based on product, Hormones, Age group, end-use, and region:
Hormonal Contraceptive, Product Outlook (Revenue - USD Billion, 2021 - 2030)
Oral contraceptive pills
Emergency contraceptive pills
Transdermal patches
Injectable birth control
Vaginal Rings
Hormonal Contraceptive, Hormones Outlook (Revenue - USD Billion, 2021 - 2030)
Combined
Progestin-only Contraceptive
Hormonal Contraceptive, Hormones Outlook (Revenue - USD Billion, 2021 - 2030)
15-24 years
25-34 years
35-44 years
Above 44 years
Hormonal Contraceptive, End-Use Outlook (Revenue - USD Billion, 2021- 2030)
Hospitals
Household
Clinics
Gynecology centers
Ambulatory Surgical Centers
Hormonal Contraceptive, Regional Outlook (Revenue - USD Billion, 2018 - 2030)
North America
U.S
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Latin America
Argentina
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
3. Research Methodology
- 3.1. Overview
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Hormonal Contraceptive Market Insights
- 4.1. Hormonal Contraceptive - Industry Snapshot
- 4.2. Hormonal Contraceptive Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rise in government and NGO initiatives to promote contraceptive methods
- 4.2.1.2. High unmet needs
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Rapidly aging population and rising prevalence of infertility
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTLE Analysis
- 4.5. Hormonal Contraceptive Industry Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Hormonal Contraceptive Market, by Product
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Hormonal Contraceptive Market, by Product, 2018 - 2030 (USD Billion)
- 5.3. Oral contraceptive pills
- 5.3.1. Global Hormonal Contraceptive Market, by Oral contraceptive pills, by Region, 2018 - 2030 (USD Billion)
- 5.4. Emergency contraceptive pills
- 5.4.1. Global Hormonal Contraceptive Market, by Emergency contraceptive pills, by Region, 2018 - 2030 (USD Billion)
- 5.5. Transdermal patches
- 5.5.1. Global Hormonal Contraceptive Market, by Transdermal patches, by Region, 2018 - 2030 (USD Billion)
- 5.6. Injectable birth control
- 5.6.1. Global Hormonal Contraceptive Market, by Injectable birth control, by Region, 2018 - 2030 (USD Billion)
- 5.7. Vaginal Rings
- 5.7.1. Global Hormonal Contraceptive Market, by Vaginal Rings, by Region, 2018 - 2030 (USD Billion)
6. Global Hormonal Contraceptive Market, by Hormones
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Hormonal Contraceptive Market, by Hormones, 2018 - 2030 (USD Billion)
- 6.3. Combined
- 6.3.1. Global Hormonal Contraceptive Market, by Combined, by Region, 2018 - 2030 (USD Billion)
- 6.4. Progestin-only Contraceptive
- 6.4.1. Global Hormonal Contraceptive Market, by Progestin-only Contraceptive, by Region, 2018 - 2030 (USD Billion)
7. Global Hormonal Contraceptive Market, by Age group
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Hormonal Contraceptive Market, by Age group, 2018 - 2030 (USD Billion)
- 7.3. 15-24 years
- 7.3.1. Global Hormonal Contraceptive Market, by 15-24 years, by Region, 2018 - 2030 (USD Billion)
- 7.4. 25-34 years
- 7.4.1. Global Hormonal Contraceptive Market, by 25-34 years, by Region, 2018 - 2030 (USD Billion)
- 7.5. 35-44 years
- 7.5.1. Global Hormonal Contraceptive Market, by 35-44 years, by Region, 2018 - 2030 (USD Billion)
- 7.6. Above 44 years
- 7.6.1. Global Hormonal Contraceptive Market, by Above 44 years, by Region, 2018 - 2030 (USD Billion)
8. Global Hormonal Contraceptive Market, by End-User
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global Hormonal Contraceptive Market, by End-User, 2018 - 2030 (USD Billion)
- 8.3. Hospitals
- 8.3.1. Global Hormonal Contraceptive Market, by Hospitals, by Region, 2018 - 2030 (USD Billion)
- 8.4. Household
- 8.4.1. Global Hormonal Contraceptive Market, by Household, by Region, 2018 - 2030 (USD Billion)
- 8.5. Clinics
- 8.5.1. Global Hormonal Contraceptive Market, by Clinics, by Region, 2018 - 2030 (USD Billion)
- 8.6. Gynecology centers
- 8.6.1. Global Hormonal Contraceptive Market, by Gynecology centers, by Region, 2018 - 2030 (USD Billion)
- 8.7. Ambulatory Surgical Centers
- 8.7.1. Global Hormonal Contraceptive Market, by Ambulatory Surgical Centers, by Region, 2018 - 2030 (USD Billion)
9. Global Hormonal Contraceptive Market, by Geography
- 9.1. Key findings
- 9.2. Introduction
- 9.2.1. Hormonal Contraceptive Market Assessment, By Geography, 2018 - 2030 (USD Billion)
- 9.3. Hormonal Contraceptive Market - North America
- 9.3.1. North America: Hormonal Contraceptive Market, by Product, 2018 - 2030 (USD Billion)
- 9.3.2. North America: Hormonal Contraceptive Market, by End-User, 2018 - 2030 (USD Billion)
- 9.3.3. North America: Hormonal Contraceptive Market, by Hormones, 2018 - 2030 (USD Billion)
- 9.3.4. North America: Hormonal Contraceptive Market, by Age group, 2018 - 2030 (USD Billion)
- 9.3.5. Hormonal Contraceptive Market - U.S.
- 9.3.5.1. U.S.: Hormonal Contraceptive Market, by Product, 2018 - 2030 (USD Billion)
- 9.3.5.2. U.S.: Hormonal Contraceptive Market, by End-User, 2018 - 2030 (USD Billion)
- 9.3.5.3. U.S.: Hormonal Contraceptive Market, by Hormones, 2018 - 2030 (USD Billion)
- 9.3.5.4. U.S.: Hormonal Contraceptive Market, by Age group, 2018 - 2030 (USD Billion)
- 9.3.6. Hormonal Contraceptive Market - Canada
- 9.3.6.1. Canada: Hormonal Contraceptive Market, by Product, 2018 - 2030 (USD Billion)
- 9.3.6.2. Canada: Hormonal Contraceptive Market, by End-User, 2018 - 2030 (USD Billion)
- 9.3.6.3. Canada: Hormonal Contraceptive Market, by Hormones, 2018 - 2030 (USD Billion)
- 9.3.6.4. Canada: Hormonal Contraceptive Market, by Age group, 2018 - 2030 (USD Billion)
- 9.4. Hormonal Contraceptive Market - Europe
- 9.4.1. Europe: Hormonal Contraceptive Market, by Product, 2018 - 2030 (USD Billion)
- 9.4.2. Europe: Hormonal Contraceptive Market, by End-User, 2018 - 2030 (USD Billion)
- 9.4.3. Europe: Hormonal Contraceptive Market, by Hormones, 2018 - 2030 (USD Billion)
- 9.4.4. Europe: Hormonal Contraceptive Market, by Age group, 2018 - 2030 (USD Billion)
- 9.4.5. Hormonal Contraceptive Market - UK
- 9.4.5.1. UK: Hormonal Contraceptive Market, by Product, 2018 - 2030 (USD Billion)
- 9.4.5.2. UK: Hormonal Contraceptive Market, by End-User, 2018 - 2030 (USD Billion)
- 9.4.5.3. UK: Hormonal Contraceptive Market, by Hormones, 2018 - 2030 (USD Billion)
- 9.4.5.4. UK: Hormonal Contraceptive Market, by Age group, 2018 - 2030 (USD Billion)
- 9.4.6. Hormonal Contraceptive Market - France
- 9.4.6.1. France: Hormonal Contraceptive Market, by Product, 2018 - 2030 (USD Billion)
- 9.4.6.2. France: Hormonal Contraceptive Market, by End-User, 2018 - 2030 (USD Billion)
- 9.4.6.3. France: Hormonal Contraceptive Market, by Hormones, 2018 - 2030 (USD Billion)
- 9.4.6.4. France: Hormonal Contraceptive Market, by Age group, 2018 - 2030 (USD Billion)
- 9.4.7. Hormonal Contraceptive Market - Germany
- 9.4.7.1. Germany: Hormonal Contraceptive Market, by Product, 2018 - 2030 (USD Billion)
- 9.4.7.2. Germany: Hormonal Contraceptive Market, by End-User, 2018 - 2030 (USD Billion)
- 9.4.7.3. Germany: Hormonal Contraceptive Market, by Hormones, 2018 - 2030 (USD Billion)
- 9.4.7.4. Germany: Hormonal Contraceptive Market, by Age group, 2018 - 2030 (USD Billion)
- 9.4.8. Hormonal Contraceptive Market - Italy
- 9.4.8.1. Italy: Hormonal Contraceptive Market, by Product, 2018 - 2030 (USD Billion)
- 9.4.8.2. Italy: Hormonal Contraceptive Market, by End-User, 2018 - 2030 (USD Billion)
- 9.4.8.3. Italy: Hormonal Contraceptive Market, by Hormones, 2018 - 2030 (USD Billion)
- 9.4.8.4. Italy: Hormonal Contraceptive Market, by Age group, 2018 - 2030 (USD Billion)
- 9.4.9. Hormonal Contraceptive Market - Spain
- 9.4.9.1. Spain: Hormonal Contraceptive Market, by Product, 2018 - 2030 (USD Billion)
- 9.4.9.2. Spain: Hormonal Contraceptive Market, by End-User, 2018 - 2030 (USD Billion)
- 9.4.9.3. Spain: Hormonal Contraceptive Market, by Hormones, 2018 - 2030 (USD Billion)
- 9.4.9.4. Spain: Hormonal Contraceptive Market, by Age group, 2018 - 2030 (USD Billion)
- 9.4.10. Hormonal Contraceptive Market - Netherlands
- 9.4.10.1. Netherlands: Hormonal Contraceptive Market, by Product, 2018 - 2030 (USD Billion)
- 9.4.10.2. Netherlands: Hormonal Contraceptive Market, by End-User, 2018 - 2030 (USD Billion)
- 9.4.10.3. Netherlands: Hormonal Contraceptive Market, by Hormones, 2018 - 2030 (USD Billion)
- 9.4.10.4. Netherlands: Hormonal Contraceptive Market, by Age group, 2018 - 2030 (USD Billion)
- 9.4.11. Hormonal Contraceptive Market - Russia
- 9.4.11.1. Russia: Hormonal Contraceptive Market, by Product, 2018 - 2030 (USD Billion)
- 9.4.11.2. Russia.: Hormonal Contraceptive Market, by End-User, 2018 - 2030 (USD Billion)
- 9.4.11.3. Russia: Hormonal Contraceptive Market, by Hormones, 2018 - 2030 (USD Billion)
- 9.4.11.4. Russia: Hormonal Contraceptive Market, by Age group, 2018 - 2030 (USD Billion)
- 9.5. Hormonal Contraceptive Market - Asia Pacific
- 9.5.1. Asia Pacific: Hormonal Contraceptive Market, by Product, 2018 - 2030 (USD Billion)
- 9.5.2. Asia Pacific: Hormonal Contraceptive Market, by End-User, 2018 - 2030 (USD Billion)
- 9.5.3. Asia Pacific: Hormonal Contraceptive Market, by Hormones, 2018 - 2030 (USD Billion)
- 9.5.4. Asia Pacific: Hormonal Contraceptive Market, by Age group, 2018 - 2030 (USD Billion)
- 9.5.5. Hormonal Contraceptive Market - China
- 9.5.5.1. China: Hormonal Contraceptive Market, by Product, 2018 - 2030 (USD Billion)
- 9.5.5.2. China.: Hormonal Contraceptive Market, by End-User, 2018 - 2030 (USD Billion)
- 9.5.5.3. China: Hormonal Contraceptive Market, by Hormones, 2018 - 2030 (USD Billion)
- 9.5.5.4. China: Hormonal Contraceptive Market, by Age group, 2018 - 2030 (USD Billion)
- 9.5.6. Hormonal Contraceptive Market - India
- 9.5.6.1. India: Hormonal Contraceptive Market, by Product, 2018 - 2030 (USD Billion)
- 9.5.6.2. India.: Hormonal Contraceptive Market, by End-User, 2018 - 2030 (USD Billion)
- 9.5.6.3. India: Hormonal Contraceptive Market, by Hormones, 2018 - 2030 (USD Billion)
- 9.5.6.4. India: Hormonal Contraceptive Market, by Age group, 2018 - 2030 (USD Billion)
- 9.5.7. Hormonal Contraceptive Market - Japan
- 9.5.7.1. Japan: Hormonal Contraceptive Market, by Product, 2018 - 2030 (USD Billion)
- 9.5.7.2. Japan.: Hormonal Contraceptive Market, by End-User, 2018 - 2030 (USD Billion)
- 9.5.7.3. Japan: Hormonal Contraceptive Market, by Hormones, 2018 - 2030 (USD Billion)
- 9.5.7.4. Japan: Hormonal Contraceptive Market, by Age group, 2018 - 2030 (USD Billion)
- 9.5.8. Hormonal Contraceptive Market - Malaysia
- 9.5.8.1. Malaysia: Hormonal Contraceptive Market, by Product, 2018 - 2030 (USD Billion)
- 9.5.8.2. Malaysia.: Hormonal Contraceptive Market, by End-User, 2018 - 2030 (USD Billion)
- 9.5.8.3. Malaysia: Hormonal Contraceptive Market, by Hormones, 2018 - 2030 (USD Billion)
- 9.5.8.4. Malaysia: Hormonal Contraceptive Market, by Age group, 2018 - 2030 (USD Billion)
- 9.5.9. Hormonal Contraceptive Market - Indonesia
- 9.5.9.1. Indonesia: Hormonal Contraceptive Market, by Product, 2018 - 2030 (USD Billion)
- 9.5.9.2. Indonesia.: Hormonal Contraceptive Market, by End-User, 2018 - 2030 (USD Billion)
- 9.5.9.3. Indonesia: Hormonal Contraceptive Market, by Hormones, 2018 - 2030 (USD Billion)
- 9.5.9.4. Indonesia: Hormonal Contraceptive Market, by Age group, 2018 - 2030 (USD Billion)
- 9.5.10. Hormonal Contraceptive Market - South Korea
- 9.5.10.1. South Korea: Hormonal Contraceptive Market, by Product, 2018 - 2030 (USD Billion)
- 9.5.10.2. South Korea.: Hormonal Contraceptive Market, by End-User, 2018 - 2030 (USD Billion)
- 9.5.10.3. South Korea: Hormonal Contraceptive Market, by Hormones, 2018 - 2030 (USD Billion)
- 9.5.10.4. South Korea: Hormonal Contraceptive Market, by Age group, 2018 - 2030 (USD Billion)
- 9.6. Hormonal Contraceptive Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Hormonal Contraceptive Market, by Product, 2018 - 2030 (USD Billion)
- 9.6.2. Middle East & Africa: Hormonal Contraceptive Market, by End-User, 2018 - 2030 (USD Billion)
- 9.6.3. Middle East & Africa: Hormonal Contraceptive Market, by Hormones, 2018 - 2030 (USD Billion)
- 9.6.4. Middle East & Africa: Hormonal Contraceptive Market, by Age group, 2018 - 2030 (USD Billion)
- 9.6.5. Hormonal Contraceptive Market - Saudi Arabia
- 9.6.5.1. Saudi Arabia: Hormonal Contraceptive Market, by Product, 2018 - 2030 (USD Billion)
- 9.6.5.2. Saudi Arabia: Hormonal Contraceptive Market, by End-User, 2018 - 2030 (USD Billion)
- 9.6.5.3. Saudi Arabia: Hormonal Contraceptive Market, by Hormones, 2018 - 2030 (USD Billion)
- 9.6.5.4. Saudi Arabia: Hormonal Contraceptive Market, by Age group, 2018 - 2030 (USD Billion)
- 9.6.6. Hormonal Contraceptive Market - South Africa
- 9.6.6.1. South Africa: Hormonal Contraceptive Market, by Product, 2018 - 2030 (USD Billion)
- 9.6.6.2. South Africa: Hormonal Contraceptive Market, by End-User, 2018 - 2030 (USD Billion)
- 9.6.6.3. South Africa: Hormonal Contraceptive Market, by Hormones, 2018 - 2030 (USD Billion)
- 9.6.6.4. South Africa: Hormonal Contraceptive Market, by Age group, 2018 - 2030 (USD Billion)
- 9.6.7. Hormonal Contraceptive Market - Israel
- 9.6.7.1. Israel: Hormonal Contraceptive Market, by Product, 2018 - 2030 (USD Billion)
- 9.6.7.2. Israel: Hormonal Contraceptive Market, by End-User, 2018 - 2030 (USD Billion)
- 9.6.7.3. Israel: Hormonal Contraceptive Market, by Hormones, 2018 - 2030 (USD Billion)
- 9.6.7.4. Israel: Hormonal Contraceptive Market, by Age group, 2018 - 2030 (USD Billion)
- 9.6.8. Hormonal Contraceptive Market - UAE
- 9.6.8.1. UAE: Hormonal Contraceptive Market, by Product, 2018 - 2030 (USD Billion)
- 9.6.8.2. UAE: Hormonal Contraceptive Market, by End-User, 2018 - 2030 (USD Billion)
- 9.6.8.3. UAE: Hormonal Contraceptive Market, by Hormones, 2018 - 2030 (USD Billion)
- 9.6.8.4. UAE: Hormonal Contraceptive Market, by Age group, 2018 - 2030 (USD Billion)
- 9.7. Hormonal Contraceptive Market - Latin America
- 9.7.1. Latin America: Hormonal Contraceptive Market, by Product, 2018 - 2030 (USD Billion)
- 9.7.2. Latin America: Hormonal Contraceptive Market, by End-User, 2018 - 2030 (USD Billion)
- 9.7.3. Latin America: Hormonal Contraceptive Market, by Hormones, 2018 - 2030 (USD Billion)
- 9.7.4. Latin America: Hormonal Contraceptive Market, by Age group, 2018 - 2030 (USD Billion)
- 9.7.5. Hormonal Contraceptive Market - Mexico
- 9.7.5.1. Mexico: Hormonal Contraceptive Market, by Product, 2018 - 2030 (USD Billion)
- 9.7.5.2. Mexico: Hormonal Contraceptive Market, by End-User, 2018 - 2030 (USD Billion)
- 9.7.5.3. Mexico: Hormonal Contraceptive Market, by Hormones, 2018 - 2030 (USD Billion)
- 9.7.5.4. Mexico: Hormonal Contraceptive Market, by Age group, 2018 - 2030 (USD Billion)
- 9.7.6. Hormonal Contraceptive Market - Brazil
- 9.7.6.1. Brazil: Hormonal Contraceptive Market, by Product, 2018 - 2030 (USD Billion)
- 9.7.6.2. Brazil: Hormonal Contraceptive Market, by End-User, 2018 - 2030 (USD Billion)
- 9.7.6.3. Brazil: Hormonal Contraceptive Market, by Hormones, 2018 - 2030 (USD Billion)
- 9.7.6.4. Brazil: Hormonal Contraceptive Market, by Age group, 2018 - 2030 (USD Billion)
- 9.7.7. Hormonal Contraceptive Market - Argentina
- 9.7.7.1. Argentina: Hormonal Contraceptive Market, by Product, 2018 - 2030 (USD Billion)
- 9.7.7.2. Argentina: Hormonal Contraceptive Market, by End-User, 2018 - 2030 (USD Billion)
- 9.7.7.3. Argentina: Hormonal Contraceptive Market, by Hormones, 2018 - 2030 (USD Billion)
- 9.7.7.4. Argentina: Hormonal Contraceptive Market, by Age group, 2018 - 2030 (USD Billion)
10. Competitive Landscape
- 10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
- 10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
- 11.1. Ansell ltd
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
- 11.2. Abbvie Inc
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
- 11.3. Afaxys inc
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
- 11.4. Agile Therapeutics
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
- 11.5. Bayer AG
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
- 11.6. Pfizer, inc
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
- 11.7. Church & Dwight,Co,Inc
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
- 11.8. Janssen Pharmaceuticals Inc
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
- 11.9. Lupin Pharmaceuticals Inc
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
- 11.10. Mylan N.V
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
- 11.11. Mayer Laboratories
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
- 11.12. Merck & co,Inc
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product Benchmarking
- 11.12.4. Recent Development
- 11.13. Organon Group of companies
- 11.13.1. Company Overview
- 11.13.2. Financial Performance
- 11.13.3. Product Benchmarking
- 11.13.4. Recent Development
- 11.14. Pregna International Ltd
- 11.14.1. Company Overview
- 11.14.2. Financial Performance
- 11.14.3. Product Benchmarking
- 11.14.4. Recent Development
- 11.15. The Female Health Company
- 11.15.1. Company Overview
- 11.15.2. Financial Performance
- 11.15.3. Product Benchmarking
- 11.15.4. Recent Development